Genexine, Inc.
KOE: 095700.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jungwon Woo
- Employees
- 86
- Headquarters
- Seongnam, South Korea
- IPO year
- 2009
- Market cap
- ₩241B
- Website
- https://www.genexine.com
Loading 095700…
Loading profile data…Frequently asked questions about 095700
What does Genexine, Inc. (095700.KQ) do?
Genexine, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of immunotherapeutics and long-acting biologics in South Korea. It develops hyFc platform, a proprietary technology designed to drive the discovery of various differentiated agonistic protein therapeutics; and the Immune Enhancing Technology,...
Where does 095700.KQ trade?
Genexine, Inc. (095700.KQ) trades on the KOSDAQ.
What sector is 095700.KQ in?
Genexine, Inc. (095700.KQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Genexine, Inc.?
Jungwon Woo is the chief executive officer of Genexine, Inc. (095700.KQ).
Where is Genexine, Inc. headquartered?
Genexine, Inc. is headquartered in South Korea.
Does 095700.KQ pay a dividend?
Genexine, Inc. (095700.KQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 095700.KQ go public?
Genexine, Inc. (095700.KQ) completed its initial public offering in 2009.